NOME Trademark

Trademark Overview


On Saturday, April 19, 2025, a trademark application was filed for NOME with the United States Patent and Trademark Office. The USPTO has given the NOME trademark a serial number of 99145505. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, September 24, 2025. This trademark is owned by Nome Therapeutics, Inc.. The NOME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software for generating, curating, and summarizing patient-specific target and variant intelligence for personalized therapy design, and automating literature review and report generation for patient cases in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for managing laboratory workflows and inventory, and managing patient intake and case files in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for electronic storage, version control, and indexing of protocols, results, and case documentation and analy...
nome

General Information


Serial Number99145505
Word MarkNOME
Filing DateSaturday, April 19, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, September 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSoftware as a service (SAAS) services featuring software for generating, curating, and summarizing patient-specific target and variant intelligence for personalized therapy design, and automating literature review and report generation for patient cases in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for managing laboratory workflows and inventory, and managing patient intake and case files in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for electronic storage, version control, and indexing of protocols, results, and case documentation and analytics in the field of drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 19, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60614

Trademark Events


Event DateEvent Description
Saturday, April 19, 2025NEW APPLICATION ENTERED
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 12, 2025ASSIGNED TO EXAMINER
Saturday, April 19, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 22, 2025NON-FINAL ACTION E-MAILED
Tuesday, September 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 22, 2025NON-FINAL ACTION WRITTEN